Heart Test Laboratories I...

NASDAQ: HSCS · Real-Time Price · USD
3.26
-0.24 (-6.86%)
At close: Aug 15, 2025, 12:08 PM

Heart Test Laboratories Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
Net Income
-8.77M -6.61M -6.35M -4.83M -2.45M
Depreciation & Amortization
127.96K 95.13K 26.91K 26.57K 33.61K
Stock-Based Compensation
249.88K 405.02K 248.31K 68.4K 24.68K
Other Working Capital
672.85K -368.36K 136.06K 691.47K 104.54K
Other Non-Cash Items
456.51K 539.23K -100.97M -35.59K -248.54K
Deferred Income Tax
n/a n/a 101.1M n/a n/a
Change in Working Capital
517.89K -504.36K 173.98K 1.12M 190.13K
Operating Cash Flow
-7.41M -6.07M -5.77M -3.64M -2.45M
Capital Expenditures
-30.19K -125.27K -18.31K -1.93K -712
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
-27.03K -60.82K n/a n/a n/a
Investing Cash Flow
-30.19K -125.27K -18.31K -1.93K -712
Debt Repayment
1.59M 42.62K -398.26K 4.23M 2.48M
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 1.31M -385.14K n/a
Financial Cash Flow
2.73M 10.34M 6.53M 3.84M 2.68M
Net Cash Flow
-4.71M 4.15M 742.21K 194.78K 226.63K
Free Cash Flow
-7.44M -6.2M -5.79M -3.65M -2.45M